跳至主要内容
临床试验/IRCT20090801002266N12
IRCT20090801002266N12招募中3 期

Efficacy of add on buprenorphine vs. placebo on reduction of relapse among people with Met Amphetamine dependency during Matrix program

Esfarayen University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • 1) People 18-60 years old 2)Having the DSM-V criteria for methamphetamine use disorder 3) It is dependent only on methamphetamine 4) No pregnancy and lactation

排除标准

  • 1)Any psychiatric disorder that require hospitalization 2) Medical condition that interfere with participating in the study 3)Any side effect that interfere with continuation of buprenorphin

研究者

发起方
Esfarayen University of Medical Sciences

相似试验